Compared with clopidogrel, the drug comes with better efficacy and less risk of major bleeding than ticagrelor.

When pain relief is needed, the agents lessen bleeding risks compared with nonselective NSAIDs, observational data suggest.

The trend is amplified by an aging population that becomes increasingly vulnerable to CVD tied to rising temperatures.

While operators from different camps have disparate views and expectations, most agree the time is right for a definitive ...

The results support the potential to change the trajectory of kidney function decline and extend life expectancy.

May is a busy but invigorating season for the TCTMD team—in-person connections abound and the stream of data never stops. The ...

From November 2024, Ami Bhatt asks Kate Dalton to share details on the challenges of early feasibility studies from her ...

A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.

Durability questions remain, but Myval appears comparable to contemporary devices on the market, says Patrick Serruys.

The curves for TVF separated early and remained parallel in the complex cases, giving an advantage to the DCB group at 1 year ...

A single infusion of a gene-editing therapy called VERVE-102, which targets PCSK9 production in the liver, shows promise for lowering LDL cholesterol in patients with heterozygous familial ...

Women continue to be underdiagnosed and undertreated for cardiovascular disease around the world—to overcome this gap, a new joint statement from the European Society of Cardiology (ESC) and other ...